Market revenue in 2022 | USD 1,899.3 million |
Market revenue in 2030 | USD 1,655.3 million |
Growth rate | -1.7% (CAGR from 2022 to 2030) |
Largest segment | Hiv |
Fastest growing segment | Herpes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | HIV, Hepatitis, Herpes, Influenza |
Key market players worldwide | Roche Holding AG, GSK PLC ADR, AbbVie Inc, Merck & Co Inc, Johnson & Johnson, Bristol-Myers Squibb Co, Dr Reddy's Laboratories Ltd ADR, Aurobindo Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antiviral drugs market will help companies and investors design strategic landscapes.
Hiv was the largest segment with a revenue share of 34.33% in 2022. Horizon Databook has segmented the Brazil antiviral drugs market based on hiv, hepatitis, herpes, influenza covering the revenue growth of each sub-segment from 2018 to 2030.
In LATAM, Brazil has the largest population. Thus, the country's viral disease incidence is high, leading to an increased demand for therapeutics. Brazil has been witnessing positive economic growth due to the region's recent financial and political stability.
The pharmaceutical industry has shown greater improvements than other industries in the country, owing to increasing government investments to enhance healthcare infrastructure. According to the WHO, since 2020, Brazil reported a high number of influenza A infections.
This rising prevalence is compelling drug manufacturers to investigate potential candidates for managing the condition. For instance, in May 2022, Merck & Co. Inc. entered into an agreement with the Institute of Drug Technology (Fiocruz) to manufacture its first oral antiviral drug for the treatment of COVID-19.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil antiviral drugs market , including forecasts for subscribers. This country databook contains high-level insights into Brazil antiviral drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account